Acrivon Therapeutics Inc (ACRV)
8.88
+0.32
(+3.74%)
USD |
NASDAQ |
May 17, 16:00
8.88
0.00 (0.00%)
After-Hours: 20:00
Acrivon Therapeutics Total Liabilities (Quarterly): 12.54M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 12.54M |
| December 31, 2023 | 17.07M |
| September 30, 2023 | 12.94M |
| June 30, 2023 | 10.86M |
| March 31, 2023 | 9.728M |
| Date | Value |
|---|---|
| December 31, 2022 | 10.75M |
| September 30, 2022 | 133.33M |
| June 30, 2022 | 131.57M |
| December 31, 2021 | 130.40M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
9.728M
Minimum
Mar 2023
133.33M
Maximum
Sep 2022
52.13M
Average
12.94M
Median
Sep 2023
Total Liabilities (Quarterly) Benchmarks
| MyMD Pharmaceuticals Inc | 5.493M |
| Vincerx Pharma Inc | 11.70M |
| GlycoMimetics Inc | 5.294M |
| Immunic Inc | 20.58M |
| Skye Bioscience Inc | 15.95M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 120.52M |
| Shareholders Equity (Quarterly) | 107.98M |